Who owns the VERTEX CELL AND GENETIC THERAPIES trademark?

The VERTEX CELL AND GENETIC THERAPIES trademark is owned by Vertex Pharmaceuticals Incorporated.

What class is the VERTEX CELL AND GENETIC THERAPIES trademark registered in?

The VERTEX CELL AND GENETIC THERAPIES trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

What is the serial number for VERTEX CELL AND GENETIC THERAPIES?

The USPTO serial number for VERTEX CELL AND GENETIC THERAPIES is 88832541.

What is the registration number for VERTEX CELL AND GENETIC THERAPIES?

VERTEX CELL AND GENETIC THERAPIES is registered under USPTO registration number 0.

VER

USPTO Trademark Record

ABANDONED

VERTEX CELL AND GENETIC THERAPIES

SN 88832541·Reg 0·Filed Mar 12, 2020

Owner Vertex Pharmaceuticals Incorporated

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

VERTEX CELL AND GENETIC THERAPIES (Serial No. 88832541), Registration No. 0, is a abandoned US trademark filed on Mar 12, 2020 by Vertex Pharmaceuticals Incorporated. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

VERTEX CELL AND GENETIC THERAPIES (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 12, 2020

SERIAL

88832541

REG#

Owner

Applicant

Vertex Pharmaceuticals Incorporated

Entity

Corporation

State

Address

50 Northern Avenue, Boston, MA, 02210

Country

Attorney

NameSteven A. Abreu

Law firm

Steven A. Abreu SUNSTEIN LLP

Docket

1618/2111

Address

100 HIGH STREET, BOSTON, MA 02110, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 12, 2020

Serial Number88832541

Registration No.0

Status DateOct 23, 2023

Published for OppositionJul 28, 2020

Mark TypeStandard characters

Attorney Docket1618/2111

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 23, 2023

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Oct 23, 2023

ABANDONMENT - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 08, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

Mar 07, 2023

SOU EXTENSION 5 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 07, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Feb 22, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Feb 22, 2023

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 28, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 26, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jul 26, 2022

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Jul 26, 2022

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 18, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Feb 16, 2022

SOU EXTENSION 3 GRANTED

SOU EXTENSION 3 FILED

Feb 16, 2022

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Feb 16, 2022

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 20, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 FILED

Aug 18, 2021

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Aug 18, 2021

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Aug 18, 2021

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 23, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Jan 21, 2021

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 21, 2021

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 21, 2021

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 22, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 28, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 28, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 08, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 21, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 17, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 17, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 17, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Jun 07, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 07, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 07, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jun 03, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 18, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 16, 2020

NEW APPLICATION ENTERED

VERTEX CELL AND GENETIC THERAPIES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Vertex Pharmaceuticals Incorporated

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Steven A. Abreu

Resources

Company